Protocol ATI001-102 Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Combination with Nivolumabin Subjects with Recurrent or Progressive Glioblastoma

Project: Research project

Description

Protocol ATI001-102 Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Combination with Nivolumab in Subjects with Recurrent or Progressive Glioblastoma
StatusActive
Effective start/end date2/21/192/28/23

Funding

  • ZIOPHARM ONCOLOGY, INC.

Fingerprint

Glioblastoma
nivolumab